| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c1e9ca62d52f315429e16851b0ebf69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5009b247629f51d36dccd92df067089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b43943ffdae2b39d53281496cdb482ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b92cfb8d271c5acc606b6656d2fa929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_458e34464b5e1a33c1cb6491d9cc4cf6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86997b915af80bd0dd7bf7fd571c2ece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee915d9f48889a2db28874e52f0d9181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e459eac9d3f1632d96d7cc0ec524ebe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4641fb68bc7893c5eb667042bb2dd3f6 |
| publicationDate |
2016-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9376715-B2 |
| titleOfInvention |
Methods for detecting mutations in the catalytic subunit of the phosphoinositol-3 kinase (PIK3CA) gene |
| abstract |
The present invention relates to means and methods for the identification of non-responders to a HER2 inhibitor, whereby one or more mutations in exon 9 of Phosphoinositol-3 kinase (PIK3CA) indicate non-responsiveness. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654105-B2 |
| priorityDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |